Gouttefangeas C - Search Results

1

Gouttefangeas C, Stenzl A, Stevanović S, Rammensee HG. Gouttefangeas C, et al. Cancer Immunol Immunother. 2007 Jan;56(1):117-28. doi: 10.1007/s00262-006-0172-4. Epub 2006 May 5. Cancer Immunol Immunother. 2007. PMID: 16676181 Free PMC article. Review.

2

Problem solving for tumor immunotherapy.

Gouttefangeas C, Rammensee HG. Gouttefangeas C, et al. Nat Biotechnol. 2000 May;18(5):491-2. doi: 10.1038/75343. Nat Biotechnol. 2000. PMID: 10802611 No abstract available.

3

Thrombocyte HLA molecules retain nonrenewable endogenous peptides of megakaryocyte lineage and do not stimulate direct allocytotoxicity in vitro.

Gouttefangeas C, Diehl M, Keilholz W, Hörnlein RF, Stevanović S, Rammensee HG. Gouttefangeas C, et al. Blood. 2000 May 15;95(10):3168-75. Blood. 2000. PMID: 10807784 Free article.

4

Identification of tumor-associated MHC class I ligands by a novel T cell-independent approach.

Schirle M, Keilholz W, Weber B, Gouttefangeas C, Dumrese T, Becker HD, Stevanović S, Rammensee HG. Schirle M, et al. Among authors: gouttefangeas c. Eur J Immunol. 2000 Aug;30(8):2216-25. doi: 10.1002/1521-4141(2000)30:8<2216::AID-IMMU2216>3.0.CO;2-7. Eur J Immunol. 2000. PMID: 10940913 Free article.

5

Functional T lymphocytes infiltrate implanted polyvinyl alcohol foams during surgical wound closure therapy.

Gouttefangeas C, Eberle M, Ruck P, Stark M, Müller JE, Becker HD, Rammensee HG, Pinocy J. Gouttefangeas C, et al. Clin Exp Immunol. 2001 Jun;124(3):398-405. doi: 10.1046/j.1365-2249.2001.01547.x. Clin Exp Immunol. 2001. PMID: 11472400 Free PMC article.

6

Human platelets express heat shock protein receptors and regulate dendritic cell maturation.

Hilf N, Singh-Jasuja H, Schwarzmaier P, Gouttefangeas C, Rammensee HG, Schild H. Hilf N, et al. Among authors: gouttefangeas c. Blood. 2002 May 15;99(10):3676-82. doi: 10.1182/blood.v99.10.3676. Blood. 2002. PMID: 11986223 Free article.

7

High frequency of human cytomegalovirus (HCMV)-specific CD8+ T cells detected in a healthy CMV-seropositive donor.

Lang KS, Moris A, Gouttefangeas C, Walter S, Teichgräber V, Miller M, Wernet D, Hamprecht K, Rammensee HG, Stevanovic S. Lang KS, et al. Among authors: gouttefangeas c. Cell Mol Life Sci. 2002 Jun;59(6):1076-80. doi: 10.1007/s00018-002-8488-5. Cell Mol Life Sci. 2002. PMID: 12169019

8

Integrated functional genomics approach for the design of patient-individual antitumor vaccines.

Weinschenk T, Gouttefangeas C, Schirle M, Obermayr F, Walter S, Schoor O, Kurek R, Loeser W, Bichler KH, Wernet D, Stevanović S, Rammensee HG. Weinschenk T, et al. Among authors: gouttefangeas c. Cancer Res. 2002 Oct 15;62(20):5818-27. Cancer Res. 2002. PMID: 12384544

9

Towards patient-specific tumor antigen selection for vaccination.

Rammensee HG, Weinschenk T, Gouttefangeas C, Stevanović S. Rammensee HG, et al. Among authors: gouttefangeas c. Immunol Rev. 2002 Oct;188:164-76. doi: 10.1034/j.1600-065x.2002.18815.x. Immunol Rev. 2002. PMID: 12445290 Review.

10

Strategies for immune therapy: Würzburg, Germany, 29 February-3 March 2004.

Pawelec G, Gouttefangeas C. Pawelec G, et al. Among authors: gouttefangeas c. Cancer Immunol Immunother. 2004 Aug;53(8):755-8. doi: 10.1007/s00262-004-0535-7. Epub 2004 May 4. Cancer Immunol Immunother. 2004. PMID: 15133632 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

113 results

Search Page